Author:
Grillo Anthony P.,Fraunfelder Frederick W.
Reference17 articles.
1. Castro AT, Mendes M, Freitas S, Roxo PC (2015) Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years. Rev Port Pneumol (2006) 21(3):144–150
2. Galor A, Ference SJ, Singh AD, Lee MS, Stevens GH, Perez VL, Peereboom DM (2007) Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Am J Ophthalmol 144(1):45–49
3. Tomi M, Hosoya K (2010) The role of blood-ocular barrier transporters in retinal drug disposition: an overview. Expert Opin Drug Metab Toxicol 6(9):1111–1124
4. Nielsen CE, Andreasen F, Bjerregaard P (1983) Amiodarone induced cornea verticillata. Acta Ophthalmol 61(3):474–480
5. Bradfield YS, Robertson DM, Salomao DR, Link TP, Rostvold JA (2003) Minocycline-induced ocular pigmentation. Arch Ophthalmol 121(1):144–145